ENDRA Life Sciences (NDRA) Long-Term Deferred Tax (2016 - 2024)

ENDRA Life Sciences (NDRA) has reported Long-Term Deferred Tax for 5 consecutive years, with $24.6 million the latest figure, recorded in Q4 2024.

• In Q4 2024, Long-Term Deferred Tax changed N/A year-over-year to $24.6 million; the TTM figure through Dec 2024 stood at $24.6 million (changed N/A YoY), while the FY2024 annual figure was $24.6 million, changed N/A from the prior year.
• Long-Term Deferred Tax climbed to $24.6 million in Q4 2024 per NDRA's latest filing, from $18.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $24.6 million in Q4 2024 and bottomed at $13.8 million in Q4 2021.
• Historically, Long-Term Deferred Tax has averaged $19.0 million across 3 years, with a median of $18.5 million in 2022.
• On a YoY basis, Long-Term Deferred Tax climbed as much as 34.05% in 2022 and fell as far as 34.05% in 2022.
• ENDRA Life Sciences' Long-Term Deferred Tax stood at $13.8 million in 2021, then soared by 34.05% to $18.5 million in 2022, then soared by 32.6% to $24.6 million in 2024.
• Business Quant data shows NDRA's Long-Term Deferred Tax at $24.6 million in Q4 2024, $18.5 million in Q4 2022, and $13.8 million in Q4 2021.